Federal funding for age-related diseases and illnesses is declining, report finds
May 24, 2011
One of the realities of the national budget crisis is that government funding for age-related health conditions — particularly Alzheimer’s — is drying up, says a new report from the Alzheimer’s...
U.S. invests $1 billion in a vaccine candidate; NIH tests multiple COVID-19 treatments
By
Alicia Lasek
Aug 07, 2020
One hundred million doses of the experimental vaccine will be stockpiled. The deal increases the likelihood that the United States will have at least one safe, effective vaccine by 2021, HHS Secretary...
NIH head says full Pfizer vaccine approval could come this summer
By
Kimberly Marselas
Jul 20, 2021
Waiting for full federal approval of Pfizer’s COVID-19 vaccine is no reason to delay protection, the director of the National Institutes of Health said Monday, but those still holding out for the end...
An IDEAL partnership for seniors
By
Jessica McKay
Jun 24, 2013
At Greenspring retirement community, we are truly dedicated to keeping residents healthy in mind, body, and spirit. A recent partnership and study highlights our efforts.
NIH panel updates treatment guidelines for non-hospitalized COVID-19 patients
By
Alicia Lasek
Jan 25, 2022
A new recommended treatments list addresses the omicron variant’s current dominance and drug supply shortages.
NIH releases COVID-19 treatment guidelines, warns against drug combo
By
Alicia Lasek
Apr 22, 2020
The comprehensive guidelines are posted in a “living document” that will be updated as new information and evidence emerges, the agency announced Tuesday.
New NIH network to recruit thousands for late-stage COVID-19 vaccine trials
By
Alicia Lasek
Jul 09, 2020
A nationwide clinical trial network will test promising COVID-19 vaccines and antibodies. There are five possible vaccine candidates.
Antigen tests just as effective as PCR in preventing COVID outbreaks, NIH study finds
By
Alicia Lasek
Jul 02, 2021
A “highly anticipated” study now shows that both testing approaches can give 98% sensitivity when used at least twice weekly in a screening program.
Robust response to virus variants expected in former COVID patients and the vaccinated
By
Alicia Lasek
Mar 31, 2021
Blood samples from recovered COVID-19 patients show that they and their vaccinated peers should be able to fend off the virus and its variants in future encounters, NIH researchers say.
U.S. to test vaccine combos for future anti-variant strategy, Fauci says
By
Alicia Lasek
Apr 01, 2022
The NIH is launching a phase 2 clinical trial to help determine which vaccine combos can provide a broader immune response in adults who have already had a series of COVID-19 vaccinations.